logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASH 2019 – Waldenström's macroglobulinemia: tirabrutinib shows high response

The second-generation Bruton’s tyrosine kinase inhibitor was well tolerated.